Mednet Logo

Is chemoradiation the preferred treatment for T2 SCC of the anal canal in a patient with IBD?

Does the presense of ulcerative colitis, now in remission, affect your dose and fields?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan-Kettering Cancer Center
Answered on

Yes, but I typically reduce the dose. In this case, 50.4 Gy in 28 fractions with 2 agent chemotherapy is a very good treatment. The worst case scenario is that the patient would need an APR. That could be because you declined to treat her or him, or because the tumor was not controlled with 50.4Gy. ...

Join for free or sign in to see the full answer